<DOC>
	<DOCNO>NCT01091103</DOCNO>
	<brief_summary>This study conduct determine effect enzalutamide androgen signal pathway correlation anti-tumor effect enzalutamide identify potential predictor response resistance therapy .</brief_summary>
	<brief_title>Determine Effect Enzalutamide ( Formerly MDV3100 ) Androgen Signaling Pathway Correlation With Anti-tumor Effects Enzalutamide Identify Potential Predictors Response Resistance Therapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Confirmed prostate cancer Presence metastatic disease bone Ongoing androgen deprivation therapy Severe concurrent disease Metastases brain</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>